Related Experiment Video
Updated: Jan 11, 2026

Author Spotlight: Porphyrin-Modified Beads for Use as Compensation Controls in Flow Cytometry
Published on: March 24, 2023
Porphyrias: Pathophysiology and clinical management recommendations for hepatologists
Andrea Ricci1, Elena Corradini, Elena Buzzetti
1Department of Medical and Surgical Science for Children and Adults,-Regional Reference Centre for Diagnosing and Management of Porphyrias, Internal Medicine and Centre for Genomic Medicine and Rare Diseases, European Reference Network on Hepatological Diseases (ERN RARE-LIVER), European Reference Network on Rare Hematological Diseases (ERN EuroBloodNet), Azienda Ospedaliero-Universitaria di Modena-Policlinico, University of Modena and Reggio Emilia, Modena, Italy.
Porphyrias, genetic disorders of heme biosynthesis, often involve the liver, regardless of classification. Recognizing and managing liver dysfunction is crucial for all porphyria patients.
Area of Science:
- Biochemistry
- Genetics
- Hepatology
Background:
- Porphyrias are a group of genetic diseases caused by enzyme dysfunction in heme biosynthesis.
- Heme is essential for numerous biological functions, with the liver being a major production site.
- Porphyrias are classified as erythropoietic or hepatic, based on the primary site of organ dysfunction.
Purpose of the Study:
- To review the liver's involvement in all types of porphyrias.
- To provide hepatologists with tools for recognizing and managing porphyrias.
- To emphasize the importance of considering porphyrias in unexplained liver disease.
Main Methods:
- Literature review of porphyria pathogenesis and clinical manifestations.
- Analysis of the liver's role in heme biosynthesis and disease pathology.
- Synthesis of clinical and diagnostic information relevant to hepatologists.
Main Results:
- All porphyrias, including those classified as erythropoietic, exhibit some degree of liver involvement.
- Hepatic dysfunction in porphyria can lead to severe clinical outcomes if overlooked.
- The liver is a key site for heme biosynthesis and a common target in porphyric diseases.
Conclusions:
- Hepatologists must consider porphyrias in the differential diagnosis of liver disease.
- A multidisciplinary approach including liver disease experts is essential for managing porphyrias.
- Early recognition and management of hepatic involvement in porphyria are critical for patient outcomes.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Acute Pancreatitis II: Clinical Manifestations and Management
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion,...
Chronic Pancreatitis II: Collaborative Care
Assessment:

